Cargando…

Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study

Reactive oxygen species (ROS) play critical roles in hepatocarcinogenesis. The catalase (CAT) enzyme is involved in the repair of ROS. Therefore, we investigate the association between CAT gene polymorphisms and the risk of hepatocellular carcinoma (HCC). A total of 715 subjects were divided into 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanqiong, Xie, Li, Zhao, Jiangyang, Huang, Xiuli, Song, Liuying, Luo, Jingrong, Ma, Liping, Li, Shan, Qin, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554034/
https://www.ncbi.nlm.nih.gov/pubmed/25837767
http://dx.doi.org/10.1097/MD.0000000000000702
_version_ 1782387997479534592
author Liu, Yanqiong
Xie, Li
Zhao, Jiangyang
Huang, Xiuli
Song, Liuying
Luo, Jingrong
Ma, Liping
Li, Shan
Qin, Xue
author_facet Liu, Yanqiong
Xie, Li
Zhao, Jiangyang
Huang, Xiuli
Song, Liuying
Luo, Jingrong
Ma, Liping
Li, Shan
Qin, Xue
author_sort Liu, Yanqiong
collection PubMed
description Reactive oxygen species (ROS) play critical roles in hepatocarcinogenesis. The catalase (CAT) enzyme is involved in the repair of ROS. Therefore, we investigate the association between CAT gene polymorphisms and the risk of hepatocellular carcinoma (HCC). A total of 715 subjects were divided into 4 groups: 111 chronic hepatitis B (CHB) patients, 90 hepatitis B virus (HBV)-related liver cirrhosis (LC) patients, 266 HBV-HCC patients, and 248 healthy controls. The polymerase chain reaction-restriction fragment length polymorphism strategy was used to detect CAT gene rs1001179, rs769217, and rs7943316 polymorphisms. Binary logistic regression analyses adjusting for sex, age, ethnicity, smoking and alcohol consumption, and body mass index suggested that subjects carrying the rs769217 T allele were at marginally increased risk of CHB, LC, and HCC, with adjusted odds ratios (ORs) of 1.51 (95% confidence interval [CI] = 1.04–2.20, P = 0.029), 1.48 (95% CI = 1.03–2.14, P = 0.035), and 1.51 (95% CI = 1.14–1.98, P = 0.004), respectively. Similarly, those individuals carrying the rs769217 TT genotype had a moderately increased risk of CHB, LC, and HCC, with adjusted ORs of 2.11 (95% CI = 1.05–4.22, P = 0.035), 2.00 (95% CI, 1.01–3.95, P = 0.047), and 1.93 (95% CI = 1.14–3.28, P = 0.015), respectively. Moreover, subjects carrying the rs769217 CT genotype and at least 1 copy of the T allele (dominant model) were 1.78 times and 1.83 times more likely to develop HCC, respectively (OR = 1.78, 95% CI = 1.16–2.73, P = 0.009 and OR = 1.83, 95% CI = 1.23–2.71, P = 0.003). This association between CAT rs769217 T alleles and HCC risk is significantly strengthened among men, nonsmokers, nondrinkers, and among individuals <50 years of age. Furthermore, we found 1 high-risk haplotype GTA for CHB (OR = 1.45, 95% CI = 1.05–2.01) and 1 protective haplotype GCA for HCC risk (OR = 0.67, 95% CI = 0.52–0.87). We did not found any significant difference in CAT rs1001179 and rs7943316 polymorphisms between controls and cases. Our findings suggest that the CAT rs769217 T allele is associated with increased risk of CHB, HBV-LC, and HBV-HCC in Guangxi population.
format Online
Article
Text
id pubmed-4554034
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-45540342015-10-27 Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study Liu, Yanqiong Xie, Li Zhao, Jiangyang Huang, Xiuli Song, Liuying Luo, Jingrong Ma, Liping Li, Shan Qin, Xue Medicine (Baltimore) 4500 Reactive oxygen species (ROS) play critical roles in hepatocarcinogenesis. The catalase (CAT) enzyme is involved in the repair of ROS. Therefore, we investigate the association between CAT gene polymorphisms and the risk of hepatocellular carcinoma (HCC). A total of 715 subjects were divided into 4 groups: 111 chronic hepatitis B (CHB) patients, 90 hepatitis B virus (HBV)-related liver cirrhosis (LC) patients, 266 HBV-HCC patients, and 248 healthy controls. The polymerase chain reaction-restriction fragment length polymorphism strategy was used to detect CAT gene rs1001179, rs769217, and rs7943316 polymorphisms. Binary logistic regression analyses adjusting for sex, age, ethnicity, smoking and alcohol consumption, and body mass index suggested that subjects carrying the rs769217 T allele were at marginally increased risk of CHB, LC, and HCC, with adjusted odds ratios (ORs) of 1.51 (95% confidence interval [CI] = 1.04–2.20, P = 0.029), 1.48 (95% CI = 1.03–2.14, P = 0.035), and 1.51 (95% CI = 1.14–1.98, P = 0.004), respectively. Similarly, those individuals carrying the rs769217 TT genotype had a moderately increased risk of CHB, LC, and HCC, with adjusted ORs of 2.11 (95% CI = 1.05–4.22, P = 0.035), 2.00 (95% CI, 1.01–3.95, P = 0.047), and 1.93 (95% CI = 1.14–3.28, P = 0.015), respectively. Moreover, subjects carrying the rs769217 CT genotype and at least 1 copy of the T allele (dominant model) were 1.78 times and 1.83 times more likely to develop HCC, respectively (OR = 1.78, 95% CI = 1.16–2.73, P = 0.009 and OR = 1.83, 95% CI = 1.23–2.71, P = 0.003). This association between CAT rs769217 T alleles and HCC risk is significantly strengthened among men, nonsmokers, nondrinkers, and among individuals <50 years of age. Furthermore, we found 1 high-risk haplotype GTA for CHB (OR = 1.45, 95% CI = 1.05–2.01) and 1 protective haplotype GCA for HCC risk (OR = 0.67, 95% CI = 0.52–0.87). We did not found any significant difference in CAT rs1001179 and rs7943316 polymorphisms between controls and cases. Our findings suggest that the CAT rs769217 T allele is associated with increased risk of CHB, HBV-LC, and HBV-HCC in Guangxi population. Wolters Kluwer Health 2015-04-03 /pmc/articles/PMC4554034/ /pubmed/25837767 http://dx.doi.org/10.1097/MD.0000000000000702 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4500
Liu, Yanqiong
Xie, Li
Zhao, Jiangyang
Huang, Xiuli
Song, Liuying
Luo, Jingrong
Ma, Liping
Li, Shan
Qin, Xue
Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study
title Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study
title_full Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study
title_fullStr Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study
title_full_unstemmed Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study
title_short Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study
title_sort association between catalase gene polymorphisms and risk of chronic hepatitis b, hepatitis b virus-related liver cirrhosis and hepatocellular carcinoma in guangxi population: a case–control study
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554034/
https://www.ncbi.nlm.nih.gov/pubmed/25837767
http://dx.doi.org/10.1097/MD.0000000000000702
work_keys_str_mv AT liuyanqiong associationbetweencatalasegenepolymorphismsandriskofchronichepatitisbhepatitisbvirusrelatedlivercirrhosisandhepatocellularcarcinomainguangxipopulationacasecontrolstudy
AT xieli associationbetweencatalasegenepolymorphismsandriskofchronichepatitisbhepatitisbvirusrelatedlivercirrhosisandhepatocellularcarcinomainguangxipopulationacasecontrolstudy
AT zhaojiangyang associationbetweencatalasegenepolymorphismsandriskofchronichepatitisbhepatitisbvirusrelatedlivercirrhosisandhepatocellularcarcinomainguangxipopulationacasecontrolstudy
AT huangxiuli associationbetweencatalasegenepolymorphismsandriskofchronichepatitisbhepatitisbvirusrelatedlivercirrhosisandhepatocellularcarcinomainguangxipopulationacasecontrolstudy
AT songliuying associationbetweencatalasegenepolymorphismsandriskofchronichepatitisbhepatitisbvirusrelatedlivercirrhosisandhepatocellularcarcinomainguangxipopulationacasecontrolstudy
AT luojingrong associationbetweencatalasegenepolymorphismsandriskofchronichepatitisbhepatitisbvirusrelatedlivercirrhosisandhepatocellularcarcinomainguangxipopulationacasecontrolstudy
AT maliping associationbetweencatalasegenepolymorphismsandriskofchronichepatitisbhepatitisbvirusrelatedlivercirrhosisandhepatocellularcarcinomainguangxipopulationacasecontrolstudy
AT lishan associationbetweencatalasegenepolymorphismsandriskofchronichepatitisbhepatitisbvirusrelatedlivercirrhosisandhepatocellularcarcinomainguangxipopulationacasecontrolstudy
AT qinxue associationbetweencatalasegenepolymorphismsandriskofchronichepatitisbhepatitisbvirusrelatedlivercirrhosisandhepatocellularcarcinomainguangxipopulationacasecontrolstudy